secwatch.observer — SEC 8-K summary ====================================== Issuer: Semnur Pharmaceuticals, Inc. (SMNR) CIK: 0001913577 Form: 8-K Filed at: 2026-04-23T23:59:59+00:00 Accession: 0001193125-26-173690 Event type: other_material Sentiment: negative Materiality: 0.75 Item codes: 1.02 LLM model: deepseek-v4-flash:cloud@v2 Semnur terminates two material financing agreements totaling $120M in potential proceeds -------------------------------------------------------------------------------- - Terminated PIPE SPA with JW Capital Securities Ltd for 1.25M shares at $16/share ($20M). - Terminated Semnur/Biconomy SPA for 6.25M shares at $16/share payable in Bitcoin ($100M). - No shares were ever issued under either agreement; both terminations effective April 20, 2026. - Company delivered termination notices under Section 8 of each SPA. Source: EDGAR index: https://www.sec.gov/Archives/edgar/data/1913577/000119312526173690/0001193125-26-173690-index.htm Primary doc: https://www.sec.gov/Archives/edgar/data/1913577/000119312526173690/smnr-20260420.htm HTML page: https://secwatch.observer/filing/0001193125-26-173690 License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer